Targeted degrader technologies as prospective SARS-CoV-2 therapies
Rabia Khurshid, Joseph M. Schulz, Jiaming Hu, Timothy S. Snowden, Robert C. Reynolds, Stephan C. Schürer
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)ProteaseDrug discovery2019-20 coronavirus outbreakDrug developmentVirologyCoronavirusPublic healthDrug resistanceMedicineAntiviral drugDrugBiologyIntensive care medicineVirusBioinformaticsPharmacologyInfectious disease (medical specialty)OutbreakMicrobiologyBiochemistryDiseaseNursingEnzymePathologyProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisHIV/AIDS drug development and treatment